Multiple Myeloma in Relapse Not Yet Recruiting Phase 1 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0036092 (Multiple Myeloma in Relapse)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03706547Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R MMTreatment